US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Vanguard Health Care ETF

311.72

-4.3600-1.38%

Post-market: 312.290.5680+0.18%19:57 EDT

Volume:193.65K

Turnover:60.70M

Market Cap:18.76B

PE:33.84

High:316.68

Open:315.93

Low:311.37

Close:316.08

52wk High:330.75

52wk Low:260.42

Shares:60.18M

Float Shares:60.18M

Volume Ratio:1.10

T/O Rate:0.32%

Dividend:4.61

Dividend Rate:1.48%

EPS(TTM):9.21

EPS(LYR):41.51

ROE:3.75%

ROA:0.89%

PB:0.95

PE(LYR):7.51

Loading ...

Overview Company News Filings

Sector Update: Healthcare Stocks Edge Higher Premarket Friday

MT Newswires Live

Johnson & Johnson Says Tremfya Significantly Improves Axial Psoriatic Arthritis Symptoms in Phase 4 Study

MT Newswires Live

Novo Bets on Next Chapter While Eli Lilly Extends Its GLP-1 Dominance

Johnson & Johnson says Tremfya met endpoints in Phase 4 STAR study

J&J - Star Study Shows Tremfya Safety Profile Consistent with Psa; no New Safety Signals

THOMSON REUTERS

J&J - Tremfya Meets Primary Endpoint for Basdai Score Improvement at Week 24

THOMSON REUTERS

J&J - Tremfya Meets Primary and Major Secondary Endpoints in Axial Psa Study

THOMSON REUTERS

Johnson & Johnson Announces Tremfya® (Guselkumab) is the First and Only Il-23 Inhibitor to Show Significant Improvement in Spinal Pain and Stiffness in Landmark Axial Psoriatic Arthritis (Psa) Study

THOMSON REUTERS

Single Infusion of Carvykti Delivered Five-Year Treatment-Free Remissions in 50% of Patients in Early Line Relapsed/Refractory Multiple Myeloma

Nektar Therapeutics - Jury Finds Lilly Breached Implied Covenant of Good Faith in License Agreement - SEC Filing

THOMSON REUTERS

J&J - Carvykti Delivers Five-Year Treatment-Free Remissions in 50% of Early Line Rrmm Patients

THOMSON REUTERS

J&J - Five-Year Overall Survival Rate 69.2%, Median Progression-Free Survival 60.5 Months

THOMSON REUTERS

FDA Approves Merck’s Welireg Plus Eisai’s Lenvima for Previously Treated Advanced Clear Cell Kidney Cancer

Surrozen price target raised to $54 from $44 at H.C. Wainwright

Estee Lauder Cos. Cl a Stock Underperforms Thursday When Compared to Competitors

Nanobiotix advances cancer nanotherapeutics and bolsters cash runway into 2029

Press Release: Clover Health Welcomes Former U.S. Senator Robert Torricelli and MedPAC Commissioner Dr. Brian J. Miller M.D. to Its Board of Directors

France's Nanobiotix H1 Net Loss Widens on Lower Revenue, Absence of 2025 One-Off Gain

Press Release: Nanobiotix Provides First Half 2026 Operational and Financial Update

FDA approves Welireg and Lenvima combo for ccRCC

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/VHT/news?page=11"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"VHT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VHT\",,,,,undefined,":{"symbol":"VHT","market":"US","secType":"STK","nameCN":"Vanguard Health Care ETF","latestPrice":311.72,"timestamp":1790884800000,"preClose":316.08,"halted":0,"volume":193649,"hourTrading":{"tag":"盘后","latestPrice":312.288,"preClose":311.72,"latestTime":"19:57 EDT","volume":149,"amount":46500.9112,"timestamp":1790899046046,"change":0.568,"changeRate":0.001822,"amplitude":0.001822},"delay":0,"changeRate":-0.01379397620855466,"floatShares":60177708,"shares":60177708,"eps":9.211173,"marketStatus":"Not Yet Opened","change":-4.36,"latestTime":"10-01 16:00:00 EDT","open":315.93,"high":316.675,"low":311.365,"amount":60698589.65956,"amplitude":0.0168,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":9.211173,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790928000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":316.08,"sharesOutstanding":59697167,"nav":315.95,"aum":19102560692.6,"dividendRate":0.014804,"bidAskSpread":0.000547,"preHourTrading":{"tag":"盘前","latestPrice":316.5475,"preClose":316.08,"latestTime":"09:29 EDT","volume":83,"amount":26257.290699999998,"timestamp":1790861398024,"change":0.4675,"changeRate":0.001479,"amplitude":0.017401},"postHourTrading":{"tag":"盘后","latestPrice":312.288,"preClose":311.72,"latestTime":"19:57 EDT","volume":149,"amount":46500.9112,"timestamp":1790899046046,"change":0.568,"changeRate":0.001822,"amplitude":0.001822},"volumeRatio":1.095107,"impliedVol":0.1828,"impliedVolPercentile":0.784},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VHT\",,,,,undefined,":{"symbol":"VHT","floatShares":60177708,"roa":"0.89%","roe":"3.75%","lyrEps":41.508655,"volumeRatio":1.095107,"shares":60177708,"dividePrice":4.6148,"high":316.675,"amplitude":0.0168,"preClose":316.08,"low":311.365,"week52Low":260.42,"pbRate":"0.95","psRate":"60.44","week52High":330.75,"institutionHeld":0,"latestPrice":311.72,"eps":9.211173,"divideRate":0.014804,"volume":193649,"delay":0,"ttmEps":9.211173,"open":315.93,"prevYearClose":287.85,"prevWeekClose":319.61,"prevMonthClose":316.08,"prevQuarterClose":316.08,"fiveDayClose":318.42,"twentyDayClose":324.47,"sixtyDayClose":306.41},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VHT\",params:#limit:5,,,undefined,":[{"date":"2026-09-23","symbol":"VHT","amount":0.9685,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-23","defaultRemindTime":1790170200000,"name":"Vanguard Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-23","currency":"USD","dateTimestamp":1790136000000,"payDate":"2026-09-25"},{"date":"2026-06-24","symbol":"VHT","amount":0.9868,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-24","defaultRemindTime":1782307800000,"name":"Vanguard Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-24","currency":"USD","dateTimestamp":1782273600000,"payDate":"2026-06-26"},{"date":"2026-03-24","symbol":"VHT","amount":0.994,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Vanguard Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-26","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-26"},{"date":"2025-12-17","symbol":"VHT","amount":1.6654,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-17","defaultRemindTime":1765981800000,"name":"Vanguard Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-17","currency":"USD","dateTimestamp":1765947600000,"payDate":"2025-12-19"},{"date":"2025-09-24","symbol":"VHT","amount":1.0765,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-24","defaultRemindTime":1758720600000,"name":"Vanguard Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-24","currency":"USD","dateTimestamp":1758686400000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VHT\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-14","recordDate":"2016-12-16","paymentDate":"2016-12-20","value":0.521,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.443,"currency":"USD"},{"executeDate":"2017-06-28","recordDate":"2017-06-30","paymentDate":"2017-07-05","value":0.498,"currency":"USD"},{"executeDate":"2017-09-27","recordDate":"2017-09-28","paymentDate":"2017-10-02","value":0.515,"currency":"USD"},{"executeDate":"2018-03-16","recordDate":"2018-03-19","paymentDate":"2018-03-21","value":0.3882,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VHT\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VHT\",pageSize:20,pageCount:11,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670440027","title":"Sector Update: Healthcare Stocks Edge Higher Premarket Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2670440027","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670440027?lang=en_us&edition=fundamental","pubTime":"2026-09-25 21:19","pubTimestamp":1790342373,"startTime":"0","endTime":"0","summary":"Healthcare stocks were edging higher premarket Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.1% and the iShares Biotechnology ETF (IBB) advancing by 0.5%.STAAR Surgical (","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2237443622.USD","SGXZ81514606.USD","LU0097036916.USD","LU0198837287.USD","LU2089984988.USD","LU2265009873.SGD","LU1868836914.USD","LU2746668974.SGD","OZEM","JDOC","BK4534","LU0316494557.USD","LU2089284900.SGD","LU2112291526.USD","LU0096364046.USD","LU0354030511.USD","LU2491050154.USD","STAA","LU0323591593.USD","LU2461242641.AUD","CANC","LU0094547139.USD","LU0210536198.USD","LU2023250330.USD","SGXZ31699556.SGD","VHT","BK4585","LU0823434583.USD","LU1712237335.SGD","TMED","IE00BJLML261.HKD","BK4139","LU1232071149.USD","IBB","LU2237443465.HKD","SG9999018857.SGD","LU2168564149.EUR","MEDX","SG9999017495.SGD","LU0106261372.USD","PJP","LU0061475181.USD","LU0385154629.USD","LU2471134523.USD","LU2746668461.USD","IE0004445239.USD","LU1868836591.USD","LU1145028129.USD","BK4516","LU1291159041.SGD","LU1323610961.USD","LU2023251221.USD","BK4533","TRUH","LU0432979614.USD","LU0158827781.USD","LU1548497426.USD","LU2106854487.HKD","PPH","SG9999015945.SGD","LU1035775433.USD","ELIS","LLII","IE0005OL40V9.USD","LLY","IE00B7KXQ091.USD","LU1720051108.HKD","LU1093756325.SGD","BK4007","LU1093756168.USD","XBI","LU2552382058.USD","LU1804176565.USD","MEDI","LU2756315318.SGD","SG9999013999.USD","LU2361044949.HKD","LU0256863902.USD","LU2552382215.SGD","IE0004445015.USD","LU0471298777.SGD","IXJ","LU0345770993.USD","SG9999015986.USD","LU1814569148.SGD","IE0009355771.USD","LU0823416689.USD","LU2023250504.SGD","IE00BFSS7M15.SGD","LU2324357040.USD","LU0820562030.AUD","LU2089283258.USD","LU0320765059.SGD","LU1974910355.USD","LU2491049909.HKD","LU1069344957.HKD","LU2087625088.SGD","LU2361044865.SGD","SGXZ57979304.SGD","LU0889565916.HKD","IE00B1XK9C88.USD","LU2361045086.USD","LU2750360997.AUD","LU2213496289.HKD","SGXZ51526630.SGD","IE00BJJMRY28.SGD","GB00BDT5M118.USD","SG9999014914.USD","LU0689472784.USD","LU2063271972.USD","LU0345770308.USD","LU0964807845.USD","LU2237438978.USD","LU0133085943.USD","IE00B4R5TH58.HKD","LU0225283273.USD","LU0174119429.USD","LU1868837300.USD","LU0006306889.USD","GDOC","LU2602419157.SGD","IE00B1BXHZ80.USD","LU0256863811.USD","LLYZ","AGNG","LU0466842654.USD","IYH","IE0001KFT4U8.USD","LU0203202063.USD","IE00BK4W5M84.HKD","LU2168564495.EUR","LU2237443549.SGD","LU2111349929.HKD","LU2417539215.USD","LU2456880835.USD","LU2896262040.SGD","LU2491050071.SGD","IE00BJJMRZ35.SGD","CURE","LU2236285917.USD","LU0456855351.SGD","LU1551013342.USD","LU2237443382.USD","BK4588","LU0683600562.USD","LU1989771016.USD","SG9999014880.SGD","LU1280957306.USD","FHLC","IE00BJT1NW94.SGD","IE00BKDWB100.SGD","LU0234572021.USD","LU1720051017.SGD","LU0158827948.USD","IE00BJJMRX11.SGD","LU2028103732.USD","LU0238689110.USD","FTXH","LU0354030438.USD","LU0823434740.USD","LU2271345857.HKD","IE00B4JS1V06.HKD","LU0289739699.SGD","LU2750360641.GBP","LU0320765992.SGD","LU2756315664.SGD","SG9999018865.SGD","LU2471134952.CNY","LU0353189680.USD","SG9999001176.USD","SG9999014906.USD","LLYX","LU0708995401.HKD","LU0672654240.SGD","BK4198","IE00BFSS8Q28.SGD","LU0943347566.SGD","LU2211815571.USD","LU2237443895.HKD","LU2237443978.SGD","LU2360106947.USD","BK4599","LU2552382132.HKD","LU1061106388.HKD","RXL","SG9999001176.SGD","SGXZ99366536.SGD","LU2471134796.USD","LU0122379950.USD","SG9999014898.SGD","LU1064131342.USD","IE00BN29S564.USD","LU2168564222.USD","LU1868836757.USD","LU0882574139.USD","LU1127390331.HKD","LU0471298694.HKD","IE00BWXC8680.SGD","LU2471134879.HKD","LU2357305700.SGD","LU0820561909.HKD","LU0109391861.USD","IHE","HRTS","LU0203201768.USD","BK4548","BK4581","IE00BKPKM429.USD","LU0109394709.USD","LU1551013425.SGD","IE00BK4W5L77.USD","LU1988902786.USD","LABU","LU0820561818.USD","LU2108987350.USD","LU2168564065.EUR","LU2462157665.USD","LU2468319806.SGD","MHIP","XLV","ELIL","LU0079474960.USD","LU1983299246.USD","LU2168563687.JPY","LU1868837136.USD","LU0266013472.USD","LU1267930730.SGD","LU1623119135.USD","LU0353189763.USD","SG9999015978.USD","LU1057294990.SGD","LU0417517546.SGD","SG9999015952.SGD","LU0640476718.USD","IE00BFTCPJ56.SGD","THNR","LU1979441026.SGD","LU0787776722.HKD","LU1366192091.USD","LU1629891620.HKD","NKTR","LU2462591350.SGD","WDNA","IE0002141913.USD","LU0882574055.USD","LU2264538146.SGD","IE00B775H168.HKD","LU0058720904.USD","FATE","LU0114720955.EUR","LU1023059063.AUD","LU0786609619.USD","IE00B2B36J28.USD","ILDR","LU1691799644.USD","LU1917777945.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670440980","title":"Johnson & Johnson Says Tremfya Significantly Improves Axial Psoriatic Arthritis Symptoms in Phase 4 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2670440980","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670440980?lang=en_us&edition=fundamental","pubTime":"2026-09-25 20:51","pubTimestamp":1790340714,"startTime":"0","endTime":"0","summary":"Johnson & Johnson  said Friday Tremfya met the primary and major secondary endpoints in a phase 4 study, showing significant improvements in axial symptoms and a reduction in MRI-confirmed inflammation in biologic-naive adults with active psoriatic arthritis and axial involvement.The primary endpoint assessed improvement in the Bath Ankylosing Spondylitis Disease Activity Index at Week 24 compared with placebo.Major secondary endpoints included significant improvements in axial symptoms measured by the Ankylosing Spondylitis Disease Activity Score using C-reactive protein and a significant reduction in MRI-confirmed inflammation of the sacroiliac joints.The safety profile was consistent with previous Tremfya data in PsA, with no new safety signals reported, the company said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1066053197.SGD","LU0057025933.USD","LU1221951046.USD","MEDX","LU2430703178.SGD","LU2129689605.HKD","FTXH","IE000BZT7R73.USD","LU0795875086.SGD","IE00BSNM7G36.USD","LU0511384066.AUD","LU0889566641.SGD","LU1003077747.HKD","TRUH","IE000SO60NU8.SGD","BK4581","IHE","VHT","LU2471134796.USD","LU0820562030.AUD","IE00B19Z3581.USD","GDOC","LU1894683348.USD","FHLC","LU1023059063.AUD","LU0795875169.SGD","LU0122379950.USD","LU0114720955.EUR","JNJ","BMED","LU0912757837.SGD","LU1585245621.USD","IXJ","XLV","IE00B2B36J28.USD","JDOC","IYH","PJP","LU1496350502.SGD","LU0289739699.SGD","IE00B3T34201.USD","LU1196500208.SGD","LU1057294990.SGD","LU0069063385.USD","LU1066051811.HKD","LU2133065610.SGD","LU1244550221.USD","LU1267930813.SGD","RXL","LU0994945656.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129613388","title":"Novo Bets on Next Chapter While Eli Lilly Extends Its GLP-1 Dominance","url":"https://stock-news.laohu8.com/highlight/detail?id=1129613388","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129613388?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:51","pubTimestamp":1790337115,"startTime":"0","endTime":"0","summary":"Novo Nordisk this week unveiled an ambitious strategy aimed at reigniting growth beyond its flagship injections Wegovy and Ozempic, but the road back to winning investors and reclaiming share in the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0266013472.USD","IE00BK4W5L77.USD","LU0106261372.USD","LU0354030438.USD","LU1623119135.USD","LU2089984988.USD","LU2213496289.HKD","ILDR","IHE","LU2237443978.SGD","BK4534","IE00BJT1NW94.SGD","MHIP","PPH","IE00BK4W5M84.HKD","LU1551013425.SGD","IE00BFTCPJ56.SGD","LU2456880835.USD","LU2462157665.USD","LU0683600562.USD","LU2462591350.SGD","LU1691799644.USD","LU1720051108.HKD","ELIS","LU0234572021.USD","LU1868836591.USD","MEDX","LU0889565916.HKD","SGXZ51526630.SGD","LU2756315318.SGD","LU0174119429.USD","LU0320765992.SGD","LU2106854487.HKD","LU2361044949.HKD","LU0061475181.USD","NVOC","CURE","IE00BKPKM429.USD","LLII","LU1814569148.SGD","SG9999015986.USD","IYH","LU0385154629.USD","LU0640476718.USD","LU2112291526.USD","SG9999014880.SGD","LU2089284900.SGD","IE00B7KXQ091.USD","SG9999018865.SGD","LU0122379950.USD","BK4533","LU0114720955.EUR","LU2211815571.USD","LU2089283258.USD","LLY","LU1804176565.USD","LU2491050071.SGD","OZEM","IE00B1BXHZ80.USD","LU2491049909.HKD","LU0353189763.USD","BK4588","LU0882574055.USD","LU1720051017.SGD","IE00BJJMRY28.SGD","LU0109391861.USD","IXJ","WDNA","LU0820561818.USD","LU2471134952.CNY","BK4599","LU1064131342.USD","LU1983299246.USD","LU2491050154.USD","LU2756315664.SGD","LU0256863902.USD","LU0672654240.SGD","LU0210536198.USD","LU1267930730.SGD","LU2471134796.USD","LU2552382058.USD","LU1868836757.USD","IE00BJJMRX11.SGD","SGXZ31699556.SGD","LU1366192091.USD","LU0787776722.HKD","LU2168564065.EUR","LU1712237335.SGD","LU0323591593.USD","LU2602419157.SGD","LU0096364046.USD","LLYX","LU0289739699.SGD","LU0097036916.USD","LU0345770993.USD","LU0345770308.USD","LU0353189680.USD","LU0256863811.USD","LLYZ","LU1023059063.AUD","LU1093756325.SGD","LU0198837287.USD","BK4516","BK4585","LU0058720904.USD","LU0432979614.USD","LU2237443382.USD","SG9999001176.USD","LU2237443465.HKD","LU0154236417.USD","LU0689472784.USD","LU2471134523.USD","BK4532","IE0004445015.USD","LU0823434583.USD","LU0823434740.USD","LU2111349929.HKD","LU0238689110.USD","LU2168564149.EUR","SGXZ99366536.SGD","LU0320765059.SGD","LU0964807845.USD","LU2237438978.USD","LU2746668461.USD","LU2552382215.SGD","CANC","LU0109394709.USD","IE00B2B36J28.USD","LU1323610961.USD","LU2361045086.USD","SGXZ81514606.USD","TMED","LU2023251221.USD","LU0820561909.HKD","SG9999014898.SGD","LU0417517546.SGD","VHT","LU2028103732.USD","AGNG","LU1061106388.HKD","SG9999001176.SGD","FHLC","TRUH","NVOH","LU0158827948.USD","ELIL","LU0158827781.USD","LU2237443622.USD","LU1629891620.HKD","LU2108987350.USD","NVOX","LU0943347566.SGD","LU2468319806.SGD","IE00BN29S564.USD","IE00BZ1G4Q59.USD","LU2271345857.HKD","LU2063271972.USD","LU2361044865.SGD","HRTS","SG9999015952.SGD","SG9999017495.SGD","IE00B1XK9C88.USD","SG9999014906.USD","SGXZ57979304.SGD","LU2461242641.AUD","LU2552382132.HKD","LU0316494557.USD","LU2023250504.SGD","NVO","IE00B4JS1V06.HKD","IE0002141913.USD","PJP","LU0471298694.HKD","LU1127390331.HKD","IE0009355771.USD","LU1280957306.USD","LU1035775433.USD","SG9999015978.USD","LU2023250330.USD","IE0001KFT4U8.USD","IE0005OL40V9.USD","GB00BDT5M118.USD","LU0456855351.SGD","LU0823416689.USD","LU1057294990.SGD","SG9999018857.SGD","LU1868836914.USD","LU1979441026.SGD","LU2746668974.SGD","LU1988902786.USD","LU1989771016.USD","IE00B775H168.HKD","GDOC","LU0471298777.SGD","LU1145028129.USD","LU1868837136.USD","XLV","LU1093756168.USD","SG9999014914.USD","LU2750360997.AUD","LU2168563687.JPY","LU1548497426.USD","LU0786609619.USD","IE0004445239.USD","LU1917777945.USD","LU0203202063.USD","LU0354030511.USD","LU1069344957.HKD","LU1291159041.SGD","LU0094547139.USD","LU2237443549.SGD","LU0882574139.USD","SG9999015945.SGD","LU2417539215.USD","LU2750360641.GBP","IE00BKVL7J92.USD","BK4581","LU0466842654.USD","IE00BJJMRZ35.SGD","IE00BJLML261.HKD","LU2087625088.SGD","LU2168564495.EUR","JDOC","LU2265009873.SGD","SG9999013999.USD","IE00BFSS7M15.SGD","BK4007","LU2324357040.USD","RXL","LU0079474960.USD","LU2360106947.USD","IE00BFSS8Q28.SGD","LU2896262040.SGD","IE00BKDWB100.SGD","LU0203201768.USD","LU0006306889.USD","LU2236285917.USD","LU0820562030.AUD","LU2471134879.HKD","IE00BWXC8680.SGD","LU1974910355.USD","LU0225283273.USD","THNR","LU1232071149.USD","LU2357305700.SGD","LU2237443895.HKD","IE00B4R5TH58.HKD","LU1551013342.USD","LU0708995401.HKD","LU2264538146.SGD","FTXH","LU2168564222.USD","MEDI","LU0133085943.USD","LU1868837300.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670427334","title":"Johnson & Johnson says Tremfya met endpoints in Phase 4 STAR study","url":"https://stock-news.laohu8.com/highlight/detail?id=2670427334","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670427334?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:35","pubTimestamp":1790336153,"startTime":"0","endTime":"0","summary":"Johnson & Johnson announced that Tremfya met the primary and major secondary endpoints demonstrating both improvement in axial symptoms and reducti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/johnson-johnson-says-tremfya-met-endpoints-in-phase-4-star-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/johnson-johnson-says-tremfya-met-endpoints-in-phase-4-star-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0203347892.USD","LU0234570918.USD","LU1551013342.USD","GDOC","LU0820561909.HKD","TRUH","LU0098860793.USD","IE00BFTCPJ56.SGD","LU1196500208.SGD","LU1496350502.SGD","RXL","VHT","FTXH","BMED","LU1280957306.USD","IYH","LU1145028129.USD","IE000M9KFDE8.USD","LU1674673428.USD","IHE","JNJ","LU0738911758.USD","LU1732799900.SGD","LU1261432733.SGD","IXJ","LU1057294990.SGD","LU1003077747.HKD","LU1066053197.SGD","MEDX","LU0889566641.SGD","LU0289961442.SGD","SGXZ57979304.SGD","PJP","IE00BZ1G4Q59.USD","BK4568","LU1032955483.USD","LU1066051498.USD","LU1221951129.SGD","LU1228905037.USD","IE00BKVL7J92.USD","LU1894683264.USD","LU0661504455.SGD","LU1244550494.USD","BK4559","SG9999002224.SGD","FHLC","XLV","JDOC","LU0820562030.AUD","IE00BLSP4239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670444217","title":"J&J - Star Study Shows Tremfya Safety Profile Consistent with Psa; no New Safety Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=2670444217","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670444217?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:30","pubTimestamp":1790335800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nTUA659LC0:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0162691827.USD","VHT","LU1496350502.SGD","LU1506573853.SGD","LU0124676726.USD","IE00B19Z3581.USD","LU0203347892.USD","GDOC","FHLC","LU0943347566.SGD","LU1074936037.SGD","BK4534","IE0034235303.USD","XLV","IHE","IE00B19Z3B42.SGD","LU2129689431.USD","LU2430703095.HKD","LU2750360641.GBP","LU0820561818.USD","LU1732799900.SGD","LU1043141123.HKD","RXL","LU0882574055.USD","IE0009355771.USD","LU1244550577.SGD","IE000WAW04H5.SGD","BMED","MEDX","LU2487616109.SGD","PJP","LU0069063385.USD","IE0002141913.USD","LU1162221912.USD","LU2750360997.AUD","LU2592432038.USD","TRUH","IYH","LU1145028129.USD","LU2236285917.USD","LU0466842654.USD","IE00BFTCPJ56.SGD","JDOC","LU1585245621.USD","FTXH","LU2347655156.SGD","LU0738911758.USD","IXJ","JNJ","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670442175","title":"J&J - Tremfya Meets Primary Endpoint for Basdai Score Improvement at Week 24","url":"https://stock-news.laohu8.com/highlight/detail?id=2670442175","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670442175?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:30","pubTimestamp":1790335800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nTUA659LC0:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1894683348.USD","LU2430703095.HKD","MEDX","IHE","LU0203345920.USD","IE0034235303.USD","LU2430703178.SGD","LU0210536198.USD","LU1032955483.USD","FTXH","IXJ","BMED","JDOC","IE000MB6IJN5.SGD","IE00BGHQF631.EUR","LU0234570918.USD","GDOC","TRUH","LU0882574055.USD","LU0689626769.HKD","VHT","LU2133065610.SGD","IYH","LU0912757837.SGD","LU1629891620.HKD","BK4559","LU0057025933.USD","FHLC","IE00BLSP4452.SGD","LU2896262040.SGD","PJP","RXL","LU0820562030.AUD","LU0289739699.SGD","LU0472753341.HKD","LU1989771016.USD","XLV","LU0345769128.USD","JNJ","IE00B4R5TH58.HKD","SG9999002232.USD","LU2471134952.CNY","LU1732800096.USD","LU1066051225.USD","LU1280957306.USD","LU2112291526.USD","LU2471134523.USD","LU2602419157.SGD","BK4592","LU1506573853.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670442172","title":"J&J - Tremfya Meets Primary and Major Secondary Endpoints in Axial Psa Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2670442172","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670442172?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:30","pubTimestamp":1790335800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nTUA659LC0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B4R5TH58.HKD","LU1228905037.USD","GDOC","LU0345770308.USD","LU2471134796.USD","BMED","IE0000B7K699.USD","LU2602419157.SGD","RXL","LU2023250330.USD","LU0210528500.USD","LU1066051225.USD","LU0234572021.USD","LU2089984988.USD","LU0466842654.USD","IE00BGHQF631.EUR","LU1244550494.USD","IE00B19Z3581.USD","IYH","BK4588","LU0320765646.SGD","LU0640476718.USD","IE00B3PB1722.GBP","TRUH","LU2129689514.USD","LU2750360997.AUD","LU2471134523.USD","MEDX","IE000F7OJYX1.SGD","LU1043141396.HKD","LU2417539215.USD","LU1162221912.USD","FHLC","IXJ","VHT","SG9999001176.USD","PJP","XLV","JNJ","JDOC","LU1430594728.SGD","LU0820561909.HKD","IE00BJJMRZ35.SGD","IHE","LU0345769128.USD","LU1023059063.AUD","LU1291159041.SGD","FTXH","IE00BLSP4239.USD","LU1894683348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670421704","title":"Johnson & Johnson Announces Tremfya® (Guselkumab) is the First and Only Il-23 Inhibitor to Show Significant Improvement in Spinal Pain and Stiffness in Landmark Axial Psoriatic Arthritis (Psa) Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2670421704","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670421704?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:30","pubTimestamp":1790335800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nTUA659LC0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1066053197.SGD","VHT","LU2403377893.USD","BK4532","LU0949170772.SGD","XLV","IE00BBT3K403.USD","PJP","JNJ","FHLC","IE0001KFT4U8.USD","LU2896262040.SGD","SGXZ57979304.SGD","BK4568","LU0320765646.SGD","SGXZ80539844.SGD","LU0162691827.USD","GDOC","LU2236285917.USD","MEDX","LU0289961442.SGD","LU1196500208.SGD","LU2756315318.SGD","IE00B19Z3B42.SGD","IE000MB6IJN5.SGD","IE00BJJMRZ35.SGD","LU0098860793.USD","IHE","LU1244550577.SGD","LU0661504455.SGD","JDOC","BK4588","IE000M9KFDE8.USD","LU0820561818.USD","LU0345770993.USD","LU1914381329.SGD","LU1066051225.USD","IXJ","RXL","TRUH","LU1032466523.USD","IYH","BMED","LU1551013342.USD","LU2089984988.USD","BK4007","LU1929549753.HKD","FTXH","LU0122379950.USD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670442334","title":"Single Infusion of Carvykti Delivered Five-Year Treatment-Free Remissions in 50% of Patients in Early Line Relapsed/Refractory Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2670442334","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670442334?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:02","pubTimestamp":1790334153,"startTime":"0","endTime":"0","summary":"BRIEF-Single Infusion Of Carvykti Delivered Five-Year Treatment-Free Remissions In 50% Of Patients In Early Line Relapsed/Refractory Multiple MyelomaSept 25 (Reuters)-Johnson & JohnsonJNJ.N:SINGLE INF","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nFWN45G1G2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF631.EUR","FHLC","LU2602419157.SGD","IE00B1BXHZ80.USD","LU0057025933.USD","VHT","BK4568","IXJ","LU1196500208.SGD","LU1228905540.USD","XLV","IE00B19Z3581.USD","IHE","PJP","SGXZ57979304.SGD","JNJ","LU0345770308.USD","JDOC","LU0689472784.USD","LU0124676726.USD","LU1894683348.USD","IE00B3T34201.USD","LU0882574055.USD","IE00BBT3K403.USD","LU0072461881.USD","SG9999001440.SGD","LU0426417589.USD","FTXH","LU0640476718.USD","MEDX","LU0545562505.USD","LU1496350502.SGD","IE00BLSP4452.SGD","GDOC","IE000WAW04H5.SGD","BMED","TRUH","LU0689626769.HKD","LU0511384066.AUD","IYH","LU2213496289.HKD","LU1032955483.USD","IE00BFXG1179.USD","BK4588","LU0943347566.SGD","LU0545039389.USD","IE00BN8TJ469.HKD","IE0002270589.USD","RXL","LU0345769128.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670442878","title":"Nektar Therapeutics - Jury Finds Lilly Breached Implied Covenant of Good Faith in License Agreement - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2670442878","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670442878?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:01","pubTimestamp":1790334099,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nFWN45G1D3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0203201768.USD","LU2213496289.HKD","SG9999014914.USD","LU1551013425.SGD","MEDX","LU2552382058.USD","BK4581","LU2106854487.HKD","IE00BK4W5L77.USD","HRTS","LU0238689110.USD","LU1061106388.HKD","LU0203202063.USD","SG9999018857.SGD","LU2271345857.HKD","LU2108987350.USD","LU0882574139.USD","LU0385154629.USD","LU1069344957.HKD","LU1267930730.SGD","IE00BN29S564.USD","LU1232071149.USD","LLYX","OZEM","LU2063271972.USD","LU1127390331.HKD","LU0354030511.USD","LU1064131342.USD","LU2168563687.JPY","LU0640476718.USD","LU2168564149.EUR","LU2237443465.HKD","LU0061475181.USD","LU2265009873.SGD","ELIS","IE00B1XK9C88.USD","LU0471298694.HKD","LU2462591350.SGD","PPH","LU2023250330.USD","LU1868836757.USD","IE00BFTCPJ56.SGD","LU2756315664.SGD","LU0417517546.SGD","LU2237438978.USD","SG9999013999.USD","IE0002141913.USD","LU0786609619.USD","LU2112291526.USD","LU1868837136.USD","LU1814569148.SGD","LU2552382132.HKD","LU1712237335.SGD","FTXH","CANC","IE0004445015.USD","LU2168564222.USD","LU2468319806.SGD","IE00BJT1NW94.SGD","SGXZ51526630.SGD","LU2491050154.USD","VHT","LU0345770993.USD","SGXZ81514606.USD","LU0345770308.USD","LU0689472784.USD","GDOC","IE00B7KXQ091.USD","SG9999015986.USD","LU1548497426.USD","LU2111349929.HKD","IE00BFSS7M15.SGD","LU0225283273.USD","LU0823434740.USD","SG9999018865.SGD","LU2324357040.USD","LU2417539215.USD","RXL","IXJ","LU2602419157.SGD","LU1280957306.USD","ELIL","LU0466842654.USD","SGXZ31699556.SGD","LLYZ","LU1691799644.USD","LU0708995401.HKD","LU2023250504.SGD","LU0256863811.USD","LU0256863902.USD","CURE","LU0672654240.SGD","LU2746668461.USD","SG9999015945.SGD","LU1093756168.USD","LU2089283258.USD","LU2023251221.USD","IE0005OL40V9.USD","LU0964807845.USD","LU0823434583.USD","LU0432979614.USD","LU1720051108.HKD","LU0058720904.USD","LU0943347566.SGD","BK4533","SG9999014906.USD","IE00BJJMRY28.SGD","LU0354030438.USD","LU1323610961.USD","LU2491050071.SGD","BK4588","LU2028103732.USD","NKTR","SGXZ99366536.SGD","WDNA","LU0158827948.USD","LU0174119429.USD","LU1291159041.SGD","LU0094547139.USD","IE00BFSS8Q28.SGD","LU0471298777.SGD","LU0109394709.USD","LU1988902786.USD","TRUH","LU0198837287.USD","LU1868837300.USD","LU1366192091.USD","LU2461242641.AUD","IE00B1BXHZ80.USD","LU0210536198.USD","LU2361044865.SGD","SGXZ57979304.SGD","BK4599","LU0133085943.USD","FHLC","LU0122379950.USD","LU0114720955.EUR","LU1989771016.USD","IE00B4R5TH58.HKD","LU2360106947.USD","LU2462157665.USD","TMED","LU2237443622.USD","LU2211815571.USD","LU1623119135.USD","LU2089284900.SGD","LU2552382215.SGD","LU2361045086.USD","MHIP","IE00B2B36J28.USD","SG9999015952.SGD","SG9999001176.SGD","LU0353189763.USD","LU0096364046.USD","LU0823416689.USD","LU1979441026.SGD","PJP","IE00BWXC8680.SGD","LU0289739699.SGD","LU0316494557.USD","LU2456880835.USD","IE00BKPKM429.USD","SG9999014898.SGD","BK4534","LU2896262040.SGD","MEDI","IE0004445239.USD","LU0097036916.USD","IE00B775H168.HKD","LU2471134879.HKD","LU2471134952.CNY","LU0456855351.SGD","LU0266013472.USD","IE0009355771.USD","AGNG","LU2237443549.SGD","BK4007","GB00BDT5M118.USD","LU0079474960.USD","LU1917777945.USD","LU0006306889.USD","IE00BJJMRX11.SGD","LU1974910355.USD","LU2237443895.HKD","LU2491049909.HKD","LU1868836591.USD","LU2264538146.SGD","IE0001KFT4U8.USD","LLII","LU0323591593.USD","LU2087625088.SGD","LU0882574055.USD","IE00BK4W5M84.HKD","IHE","LU2471134796.USD","LU0106261372.USD","LU0109391861.USD","LU0320765992.SGD","LU0820562030.AUD","LU0889565916.HKD","LU2089984988.USD","BK4585","LU0320765059.SGD","ILDR","LU1023059063.AUD","LU2357305700.SGD","LU0158827781.USD","LU2750360641.GBP","LU1629891620.HKD","THNR","LU0683600562.USD","LU2746668974.SGD","SG9999001176.USD","LU1551013342.USD","SG9999015978.USD","LU2236285917.USD","LU2756315318.SGD","LU2168564495.EUR","XLV","IE00BJLML261.HKD","SG9999017495.SGD","LU0820561909.HKD","BK4516","JDOC","LLY","LU0820561818.USD","LU1145028129.USD","LU1804176565.USD","IYH","IE00BKDWB100.SGD","LU2237443382.USD","LU0234572021.USD","LU2471134523.USD","SG9999014880.SGD","LU0353189680.USD","LU1035775433.USD","LU1057294990.SGD","LU1720051017.SGD","LU1983299246.USD","LU2361044949.HKD","LU2750360997.AUD","LU2237443978.SGD","IE00B4JS1V06.HKD","LU1093756325.SGD","IE00BJJMRZ35.SGD","LU1868836914.USD","LU0787776722.HKD","LU2168564065.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670444072","title":"J&J - Carvykti Delivers Five-Year Treatment-Free Remissions in 50% of Early Line Rrmm Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2670444072","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670444072?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:00","pubTimestamp":1790334004,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nFWN45G1G2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0072461881.USD","LU2471134523.USD","LU2112291526.USD","FHLC","BMED","LU0234570918.USD","LU0787776722.HKD","LU1121112475.USD","LU1894683264.USD","LU0124676726.USD","XLV","IE00BVYPNV92.GBP","MEDX","LU0949170772.SGD","LU2089984988.USD","LU0069063385.USD","BK4592","IYH","VHT","JDOC","RXL","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","BK4559","LU0738911758.USD","LU1057294990.SGD","LU1280957306.USD","TRUH","LU0820561909.HKD","LU1066051811.HKD","JNJ","BK4534","IXJ","LU0070217475.USD","LU1244550221.USD","LU0203347892.USD","IE00BSNM7G36.USD","LU0553294199.USD","LU2471134796.USD","IHE","LU1043141396.HKD","GDOC","BK4581","FTXH","IE000WAW04H5.SGD","SG9999002232.USD","LU0426417589.USD","LU0820562030.AUD","LU1261432733.SGD","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670440474","title":"J&J - Five-Year Overall Survival Rate 69.2%, Median Progression-Free Survival 60.5 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2670440474","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670440474?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:00","pubTimestamp":1790334004,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nFWN45G1G2:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDX","RXL","LU2347655156.SGD","LU1894683348.USD","LU0545562505.USD","BK4585","JDOC","FHLC","IE00BDGV0183.EUR","LU1989771016.USD","IHE","LU1732799900.SGD","FTXH","LU1280957306.USD","PJP","LU0345770993.USD","LU2750360641.GBP","GDOC","LU1196500208.SGD","IE00BFXG1179.USD","LU0985320562.USD","IYH","LU0511384066.AUD","LU1043141123.HKD","LU1032466523.USD","IE00BN8TJ469.HKD","IE00BKVL7J92.USD","XLV","JNJ","LU0426412945.USD","LU1674673691.USD","VHT","LU0949170772.SGD","LU2023250330.USD","LU0122379950.USD","LU0210536198.USD","LU1261432733.SGD","LU0098860793.USD","TRUH","BMED","BK4532","LU0289961442.SGD","LU0738911758.USD","SG9999013999.USD","IE00BBT3K403.USD","LU2505996681.GBP","LU0689472784.USD","IXJ","LU2129689431.USD","LU0553294199.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670544444","title":"FDA Approves Merck’s Welireg Plus Eisai’s Lenvima for Previously Treated Advanced Clear Cell Kidney Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2670544444","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670544444?lang=en_us&edition=fundamental","pubTime":"2026-09-25 18:45","pubTimestamp":1790333155,"startTime":"0","endTime":"0","summary":"FDA approves Merck’s Welireg plus Eisai’s Lenvima for previously treated advanced clear cell kidney cancerFDA cleared Merck’s WELIREG with Eisai’s LENVIMA for previously treated adults with advanced clear cell renal cell carcinoma.Use targets patients whose disease progressed on a PD-1 or PD-L1 inhibitor.Phase 3 LITESPARK-011 showed median PFS of 14.6 months vs 10.6 months with cabozantinib; HR 0.74.Overall survival missed statistical significance at final analysis; objective response rate was 53% vs 40%.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merck & Co. Inc. published the original content used to generate this news brief via Business Wire  on September 25, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nNDL8yld87:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRK","BK4516","LU1116320901.HKD","BK4585","LU1037948897.HKD","LU0265550946.USD","LU2357627491.SGD","LU2361045086.USD","LU1934455863.HKD","BK4588","LU0320765646.SGD","LU0432979614.USD","LU0965508806.USD","PPH","LU0266013472.USD","LU1983299246.USD","LU1061106388.HKD","LU1066051811.HKD","LU2089984988.USD","IE00BLSP4452.SGD","LU0823416689.USD","LU0965509010.AUD","LU2112291526.USD","LU1057294990.SGD","BMED","LU0265550359.USD","FHLC","SG9999014567.USD","TRUH","LU0057025933.USD","LU0289739699.SGD","LU0477156953.USD","LU1941712264.USD","IYH","LU0868494617.USD","LU2106854487.HKD","SG9999013999.USD","FTXH","LU0942090050.USD","LU1923622614.USD","LU0289961442.SGD","BK4559","LU1917777945.USD","LU2360032135.SGD","LU1032466523.USD","LU1699723380.USD","LU2125154778.USD","SG9999015341.SGD","JDOC","LU1201861249.SGD","LU1093756325.SGD","LU0234572021.USD","IE00BBT3K403.USD","LU2361044865.SGD","IE00B1BXHZ80.USD","IE00B2B36J28.USD","LU1066051225.USD","LU2491049909.HKD","LU0472753341.HKD","LU2433249047.HKD","RXL","LU1093756168.USD","IE00BLSP4239.USD","LU0985320562.USD","SGXZ57979304.SGD","LU0069063385.USD","LU1066053197.SGD","IE0009355771.USD","LU2491050071.SGD","GDOC","BK4550","LU1989771016.USD","LU1430594728.SGD","LU2125909247.SGD","LU2023250843.SGD","LU0006306889.USD","IE00BSNM7G36.USD","LU1571399168.USD","IE000M9KFDE8.USD","SG9999001176.SGD","LU0868494708.USD","LU1162221912.USD","LU2461242641.AUD","LU1989772923.USD","BK4534","LU1023059063.AUD","LU0511384066.AUD","XLV","LU0965509101.SGD","LU1989772840.SGD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","SG9999002232.USD","SG9999014542.SGD","LU2468319806.SGD","PAWZ","SG9999014575.USD","LU1934455194.USD","LU2125909593.SGD","IXJ","IE00BFTCPJ56.SGD","LU1941712348.USD","LU1934455277.USD","LU0098860793.USD","LU1066051498.USD","SG9999015358.SGD","LU2324357040.USD","LU0106261372.USD","LU2125154935.USD","BK4533","LU0203347892.USD","LU0980610538.SGD","SG9999001176.USD","IHE","LU0058720904.USD","LU0124676726.USD","IE00BJJMRZ35.SGD","LU0208291251.USD","LU0859254822.USD","LU0861579265.USD","VHT","LU0320765489.SGD","SG9999014559.SGD","LU1037948541.HKD","BK4007","LU0072461881.USD","LU0211331839.USD","LU1291159041.SGD","SG9999001440.SGD","SG9999002224.SGD","LU0689626769.HKD","LU0130102774.USD","LU0122379950.USD","LU0648001328.SGD","LU0130517989.USD","LU1974910355.USD","LU0070302665.USD","LU0238689110.USD","LU0289739343.SGD","LU1929549753.HKD","HRTS","IE0002141913.USD","LU0162691827.USD","LU0203345920.USD","LU1069347547.HKD","LU1035773651.USD","LU2023250504.SGD","LU1585245621.USD","LU2491050154.USD","LU2361044949.HKD","LU1116320737.USD","IE00BN8TJ469.HKD","LU0965509283.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670444358","title":"Surrozen price target raised to $54 from $44 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2670444358","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670444358?lang=en_us&edition=fundamental","pubTime":"2026-09-25 18:10","pubTimestamp":1790331041,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on Surrozen (SRZN) to $54 from $44 and keeps a Buy rating on the shares. The firm believes Merck’s (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/surrozen-price-target-raised-to-54-from-44-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/surrozen-price-target-raised-to-54-from-44-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2433249047.HKD","FTXH","LU0070302665.USD","LU1069347547.HKD","IE00BLSP4239.USD","LU2360032135.SGD","FHLC","IHE","LU0130102774.USD","MRK","LU0823416689.USD","PAWZ","LU1035773651.USD","BK4588","LU2361045086.USD","HRTS","LU0965508806.USD","GDOC","LU1923622614.USD","JDOC","LU1934455863.HKD","LU1989772923.USD","LU0265550946.USD","LU1917777945.USD","BMED","LU1941712348.USD","SRZN","SG9999002224.SGD","LU2125909247.SGD","LU0289961442.SGD","LU2491049909.HKD","IXJ","RXL","LU1934455277.USD","TRUH","LU0208291251.USD","LU1116320901.HKD","LU1037948897.HKD","VHT","IYH","LU1093756325.SGD","LU2361044949.HKD","LU1093756168.USD","LU2361044865.SGD","PPH","XLV","LU0689626769.HKD","LU0057025933.USD","SG9999015341.SGD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670413314","title":"Estee Lauder Cos. Cl a Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2670413314","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670413314?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:55","pubTimestamp":1790283300,"startTime":"0","endTime":"0","summary":"DJ Estee Lauder Cos. Cl A Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Estee Lauder Cos. Cl A  slipped 3.50% to $95.37 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.02% to 7,704.13 and Dow Jones Industrial Average  falling 0.31% to 51,349.98.This was the stock's second consecutive day of losses.Estee Lauder Cos. Cl A closed 21.59% below its 52-week high of $121.64, which the company reached on February 3rd.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  rose 0.56% to $270.68, Procter & Gamble Co.  fell 1.16% to $145.68, and Coty Inc. Cl A  fell 0.38% to $2.63.Trading volume  eclipsed its 50-day average volume of 3.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 24, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXL","XLP","FSTA","JNJ","UGE","LU2347655156.SGD","BMED","LU1043141396.HKD","LU1066051811.HKD","GLAM","LU0942090050.USD","SG9999014542.SGD","XLV","MEDX","VHT","IYH","FTXH","BK4585","GDOC","IE000MB6IJN5.SGD","IHE","PG","LU2264538146.SGD","LU2552382132.HKD","LU0057025933.USD","LU0553294199.USD","LU1585245621.USD","EL","BK4533","LU1674673428.USD","IE00BSNM7G36.USD","LU1914381329.SGD","PJP","LU2592432038.USD","TRUH","JDOC","IE00BFTCPJ56.SGD","IE000BZT7R73.USD","TRUO","LU2750360641.GBP","FHLC","SG9999014575.USD","LU0795875169.SGD","LU0114720955.EUR","IE0034235303.USD","LU0738911758.USD","IXJ","IE00BBT3K403.USD","COTY","IE00B1XK9C88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670187634","title":"Nanobiotix advances cancer nanotherapeutics and bolsters cash runway into 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2670187634","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670187634?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:32","pubTimestamp":1790281948,"startTime":"0","endTime":"0","summary":"Nanobiotix ( ($FR:NANO) ) just unveiled an announcement. Nanobiotix reported encouraging clinical progress for its lead nanoradioenhancer JNJ-1900 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nanobiotix-advances-cancer-nanotherapeutics-and-bolsters-cash-runway-into-2029?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nanobiotix-advances-cancer-nanotherapeutics-and-bolsters-cash-runway-into-2029?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE000SO60NU8.SGD","SG9999001440.SGD","IE000WAW04H5.SGD","NANO","LU1244550494.USD","LU2505996681.GBP","LU0053666078.USD","JNJ","IE00BLSP4452.SGD","LU0795875169.SGD","BMED","LU0098860793.USD","LU2129689605.HKD","TRUH","LU0070217475.USD","IE00BDGV0183.EUR","LU2471134952.CNY","LU0640476718.USD","MEDX","LU0820562030.AUD","JDOC","LU0738911758.USD","IHE","LU1894683348.USD","RXL","BK4007","FHLC","IYH","LU0234572021.USD","LU2756315318.SGD","VHT","BK4532","FTXH","LU2430703178.SGD","PJP","LU0122379950.USD","LU1914381329.SGD","XLV","LU2471134523.USD","IE00B3T34201.USD","LU2756315664.SGD","LU0057025933.USD","LU2133065610.SGD","LU1066051811.HKD","LU1585245621.USD","GDOC","LU2089984988.USD","LU2750360641.GBP","IXJ","LU0466842654.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670153418","title":"Press Release: Clover Health Welcomes Former U.S. Senator Robert Torricelli and MedPAC Commissioner Dr. Brian J. Miller M.D. to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2670153418","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670153418?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:30","pubTimestamp":1790281800,"startTime":"0","endTime":"0","summary":"WILMINGTON, Del., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (\"Clover,\" \"Clover Health\" or the \"Company\") today announced the appointments of former U.S. Senato","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","MLR","BK4550","BK4149","VHT","BK4588","BK4585","TCAF","IXJ","NOBL","CGCV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670941892","title":"France's Nanobiotix H1 Net Loss Widens on Lower Revenue, Absence of 2025 One-Off Gain","url":"https://stock-news.laohu8.com/highlight/detail?id=2670941892","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670941892?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:24","pubTimestamp":1790281482,"startTime":"0","endTime":"0","summary":"France's Nanobiotix H1 net loss widens on lower revenue, absence of 2025 one-off gainOverviewFrance-based biotech firm's H1 2026 revenue declined due to prior year one-off non-cash impactNet loss wide","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL1N45G12R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053666078.USD","LU2896262040.SGD","IE000WAW04H5.SGD","IE0001KFT4U8.USD","LU1506573853.SGD","JDOC","IXJ","IE00B4R5TH58.HKD","IE00BGHQF631.EUR","LU2750360997.AUD","LU1121112475.USD","GDOC","LU0114720955.EUR","LU0098860793.USD","PJP","LU1496350502.SGD","IHE","SGXZ57979304.SGD","LU2430703251.USD","LU0949170772.SGD","VHT","LU0162691827.USD","LU2112291526.USD","XLV","LU1162221912.USD","FTXH","LU0792757196.USD","LU1032466523.USD","MEDX","LU0345769631.USD","SG9999001176.SGD","JNJ","LU0072461881.USD","FHLC","TRUH","BMED","IE0000B7K699.USD","LU0345769128.USD","BK4588","LU1221951046.USD","LU0889566641.SGD","LU2089984988.USD","LU0289961442.SGD","IYH","LU0210528500.USD","LU0545039389.USD","IE00B19Z3581.USD","LU0795875086.SGD","RXL","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670418519","title":"Press Release: Nanobiotix Provides First Half 2026 Operational and Financial Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2670418519","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670418519?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:15","pubTimestamp":1790280900,"startTime":"0","endTime":"0","summary":"-- Promising early results reported from full cohort analysis of the. completed dose-escalation and expansion phases of a Phase 1 study. recurrent non-small cell lung cancer  amenable to re-irradiation. -- Strengthened financial position through an oversubscribed EUR86 million. global follow-on offering completed in May 2026, extending cash runway. -- Acceptable safety profile and promising initial efficacy responses. observed in Johnson & Johnson-led Phase 2 CONVERGE study evaluating. Phase 3 NANORAY-312 study evaluating JNJ-1900  in locally. Anderson Cancer Center  presented at 2026 WCLC Meeting:. control rate was 79%. One-year local progression-free survival.  was 61%, and one-year overall survival  was 70% in. clinically meaningful local control using a substantially lower. -- All 24 patients completed treatment with JNJ-1900  plus","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0057025933.USD","SG9999001176.USD","BK4559","LU1551013342.USD","LU2756315664.SGD","IE000SO60NU8.SGD","LU0994945656.USD","BK4534","JNJ","GDOC","LU1066051225.USD","LU0912757837.SGD","VHT","BK4592","BMED","LU1244550577.SGD","IE00BN8TJ469.HKD","FHLC","LU0289739343.SGD","NBTX","LU0345769631.USD","LU1989771016.USD","BK4532","LU0234570918.USD","LU1674673428.USD","PJP","LU0345770308.USD","LU1894683264.USD","IE00BVYPNW00.USD","LU0234572021.USD","FTXH","TRUH","XLV","LU0210528500.USD","SG9999001176.SGD","LU0738911758.USD","SGXZ80539844.SGD","LU1629891620.HKD","MEDX","BK4139","BK4007","IHE","IE00B19Z3581.USD","JDOC","IYH","IXJ","SG9999013999.USD","SG9999001440.SGD","RXL","LU0689472784.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670490795","title":"FDA approves Welireg and Lenvima combo for ccRCC","url":"https://stock-news.laohu8.com/highlight/detail?id=2670490795","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670490795?lang=en_us&edition=fundamental","pubTime":"2026-09-25 03:35","pubTimestamp":1790278513,"startTime":"0","endTime":"0","summary":"The Food and Drug Administration approved Welireg from Merck (MRK) in combination with Lenvima from Eisai (ESAIY) for adults with advanced renal ce...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-approves-welireg-and-lenvima-combo-for-ccrcc-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-approves-welireg-and-lenvima-combo-for-ccrcc-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1929549753.HKD","LU2125909247.SGD","LU1571399168.USD","SG9999001440.SGD","LU1035773651.USD","LU0265550359.USD","VHT","LU0070302665.USD","LU0985320562.USD","LU0130102774.USD","LU2461242641.AUD","LU0238689110.USD","LU1917777945.USD","LU1989771016.USD","SG9999001176.SGD","IE00B4R5TH58.HKD","FHLC","LU0072461881.USD","LU0208291251.USD","LU0965509010.AUD","IE00B1BXHZ80.USD","LU0265550946.USD","IE00BLSP4452.SGD","SG9999014575.USD","LU0648001328.SGD","LU1116320901.HKD","LU1037948541.HKD","BK4588","LU0320765646.SGD","LU0069063385.USD","LU1116320737.USD","LU0289961442.SGD","LU1923622614.USD","LU2324357040.USD","LU0124676726.USD","MRK","SG9999002232.USD","LU1974910355.USD","LU1585245621.USD","LU0098860793.USD","LU0057025933.USD","LU0289739343.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","LU2361045086.USD","LU1934455277.USD","LU2468319806.SGD","LU1699723380.USD","BK4585","IE00BJJMRZ35.SGD","LU2361044949.HKD","IYH","LU0432979614.USD","LU1093756325.SGD","BK4559","TRUH","LU1941712348.USD","LU0122379950.USD","LU1037948897.HKD","LU0965509101.SGD","LU1989772840.SGD","LU1201861249.SGD","BK4007","LU0859254822.USD","LU2125909593.SGD","LU2357627491.SGD","IE00BBT3K403.USD","SG9999015358.SGD","LU1061106388.HKD","LU0162691827.USD","LU1066053197.SGD","PPH","LU0266013472.USD","LU0211331839.USD","ESAIY","IE00BN8TJ469.HKD","LU2089984988.USD","LU1069347547.HKD","LU2125154778.USD","LU1934455863.HKD","RXL","LU1989772923.USD","LU2106854487.HKD","LU1066051811.HKD","GDOC","BK4534","BMED","LU0868494617.USD","LU2125154935.USD","FTXH","LU2023250504.SGD","LU0965509283.SGD","SG9999001176.USD","XLV","JDOC","SG9999002224.SGD","BK4550","LU0868494708.USD","SG9999014559.SGD","IXJ","SG9999014567.USD","LU0861579265.USD","LU0203345920.USD","LU1162221912.USD","LU1934455194.USD","SGXZ57979304.SGD","LU1983299246.USD","BK4533","LU1093756168.USD","SG9999013999.USD","IE00BFTCPJ56.SGD","LU1941712264.USD","SG9999015341.SGD","IE00BSNM7G36.USD","HRTS","LU1066051225.USD","LU0965508806.USD","LU0320765489.SGD","LU0130517989.USD","LU0289739699.SGD","LU0942090050.USD","LU0058720904.USD","LU0689626769.HKD","LU0472753341.HKD","LU2112291526.USD","LU2360032135.SGD","LU2491049909.HKD","IE0002141913.USD","LU0980610538.SGD","LU1057294990.SGD","LU1430594728.SGD","LU0823416689.USD","LU1066051498.USD","SG9999014542.SGD","LU2361044865.SGD","LU1291159041.SGD","LU0511384066.AUD","LU2491050154.USD","LU0006306889.USD","LU0477156953.USD","LU0203347892.USD","LU2491050071.SGD","IHE","IE00B2B36J28.USD","LU2023250843.SGD","LU2433249047.HKD","BK4516","LU0234572021.USD","IE00BLSP4239.USD","LU0106261372.USD","LU1023059063.AUD","LU1032466523.USD","PAWZ","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":18,"pageCount":11,"totalSize":354,"code":"91000000","status":"200"}]}}